Valeant (VRX) Answered Its Questions Well, But Other Questions Remain - Deutsche Bank

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/20/2026

1. NVDA
2. SPY
3. META
4. EYPT
5. AMZN
6. TSLA
7. CRWV
8. SPCX
9. CLF
10. IRON

Go back to Valeant (VRX) Answered Its Questions Well, But Other Questions Remain - Deutsche Bank

Statements Of J. Michael Pearson, Chairman And CEO, And Robert Ingram, Lead Outside Director Of Valeant Pharmaceuticals

October 26, 2015 9:00 AM EDT

LAVAL, Quebec, Oct. 26, 2015 /PRNewswire/ -- J. Michael Pearson, Chairman and Chief Executive Officer of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX), made the following statements on today's investor call.

Statement of J. Michael Pearson:

"We wanted to hold this call today because the company I've heard described in the press the past few days is not one that I recognize. It's not one that our board of directors recognizes. And it's certainly not one that reflects the... More